Vanguard Group’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,685
| Closed | -$15.4K | – | 4492 |
|
|
2024
Q1 | $15.4K | Hold |
1,685
| – | – | ﹤0.01% | 4408 |
|
|
2023
Q4 | $9.68K | Hold |
1,685
| – | – | ﹤0.01% | 4479 |
|
|
2023
Q3 | $13.2K | Sell |
1,685
-2,768
| -62% | -$69.7K | ﹤0.01% | 4515 |
|
|
2023
Q2 | $237K | Hold |
4,453
| – | – | ﹤0.01% | 4284 |
|
|
2023
Q1 | $295K | Buy |
4,453
+142
| +3% | +$10.3K | ﹤0.01% | 4253 |
|
|
2022
Q4 | $173K | Buy |
4,311
+4
| +0.1% | +$238 | ﹤0.01% | 4332 |
|
|
2022
Q3 | $309K | Sell |
4,307
-458
| -10% | -$30.9K | ﹤0.01% | 4338 |
|
|
2022
Q2 | $257K | Sell |
4,765
-110
| -2% | -$7.77K | ﹤0.01% | 4433 |
|
|
2022
Q1 | $620K | Hold |
4,875
| – | – | ﹤0.01% | 4344 |
|
|
2021
Q4 | $576K | Hold |
4,875
| – | – | ﹤0.01% | 4404 |
|
|
2021
Q3 | $701K | Buy |
4,875
+66
| +1% | +$11.1K | ﹤0.01% | 4322 |
|
|
2021
Q2 | $985K | Buy |
4,809
+1,577
| +49% | +$351K | ﹤0.01% | 4149 |
|
|
2021
Q1 | $972K | Buy |
+3,232
| New | +$1.09M | ﹤0.01% | 4016 |
|
|
2020
Q1 | – | Sell |
-108
| Closed | -$18K | – | 4102 |
|
|
2019
Q4 | $18K | Hold |
108
| – | – | ﹤0.01% | 4095 |
|
|
2019
Q3 | $52K | Hold |
108
| – | – | ﹤0.01% | 4083 |
|
|
2019
Q2 | $98K | Hold |
108
| – | – | ﹤0.01% | 4051 |
|
|
2019
Q1 | $118K | Hold |
108
| – | – | ﹤0.01% | 3999 |
|
|
2018
Q4 | $86K | Hold |
108
| – | – | ﹤0.01% | 4014 |
|
|
2018
Q3 | $147K | Hold |
108
| – | – | ﹤0.01% | 4042 |
|
|
2018
Q2 | $146K | Buy |
108
+39
| +57% | +$61.8K | ﹤0.01% | 4019 |
|
|
2018
Q1 | $129K | Buy |
+69
| New | +$117K | ﹤0.01% | 4011 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | -$4K | – | 4086 |
|
|
2017
Q1 | $4K | Hold |
1
| – | – | ﹤0.01% | 4067 |
|
|
2016
Q4 | $4K | Sell |
1
-7
| -88% | -$26.9K | ﹤0.01% | 4076 |
|
|
2016
Q3 | $35K | Sell |
8
-3
| -27% | -$15.2K | ﹤0.01% | 4053 |
|
|
2016
Q2 | $88K | Hold |
11
| – | – | ﹤0.01% | 4036 |
|
|
2016
Q1 | $201K | Hold |
11
| – | – | ﹤0.01% | 3961 |
|
|
2015
Q4 | $163K | Buy |
11
+1
| +10% | +$20.2K | ﹤0.01% | 4032 |
|
|
2015
Q3 | $134K | Hold |
10
| – | – | ﹤0.01% | 4070 |
|
|
2015
Q2 | $365K | Hold |
10
| – | – | ﹤0.01% | 3945 |
|
|
2015
Q1 | $349K | Buy |
10
+1
| +11% | +$32K | ﹤0.01% | 3909 |
|
|
2014
Q4 | $215K | Hold |
9
| – | – | ﹤0.01% | 3893 |
|
|
2014
Q3 | $490K | Sell |
9
-1
| -10% | -$43.2K | ﹤0.01% | 3716 |
|
|
2014
Q2 | $477K | Hold |
10
| – | – | ﹤0.01% | 3694 |
|
|
2014
Q1 | $713K | Buy |
10
+2
| +25% | +$158K | ﹤0.01% | 3557 |
|
|
2013
Q4 | $603K | Hold |
8
| – | – | ﹤0.01% | 3544 |
|
|
2013
Q3 | $603K | Hold |
8
| – | – | ﹤0.01% | 3505 |
|
|
2013
Q2 | $679K | Buy |
+8
| New | +$773K | ﹤0.01% | 3405 |
|
Vanguard Group's YTEN Position: Q2 2024 in Review
Vanguard Group sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 1,685 shares — an estimated $15.4K sold.
Vanguard Group first reported a position in YTEN in Q2 2013 and held it in 37 quarters. The position peaked at $985K in Q2 2021. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- Vanguard Group reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Vanguard Group sold 1,685 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $15.4K.
- Vanguard Group first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 37 quarters.
- Vanguard Group's Yield10 Bioscience, Inc. Common Stock position peaked at $985K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.